FDA Inspection
BloodworksBloodworks – FDA Inspection, Feb 15, 2013
Record Details
This FDA Inspection record concerns Bloodworks, with an inspection on February 15, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Bloodworks
- Inspection Date
- February 15, 2013
- Product Type
- Biologics
View Company Profile
ID · 52e601cf-08cf-4082-99b8-165cd825e531
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 819984
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Bloodworks
15| Date | Classification | Office | Project area |
|---|---|---|---|
| December 11, 2025 | Not classified | Seattle District Office | Blood and Blood Products |
| May 3, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 16, 2021 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 18, 2019 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 7, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Bloodworks
- FDA Inspection 1294906 - 2025-12-11
- FDA Inspection 1238690 - 2024-05-03
- FDA Inspection 1146276 - 2021-07-16
- FDA Inspection 1087821 - 2019-04-18
- FDA Inspection 1056331 - 2018-06-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.